Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: Results of Korean multicenter angioplasty team (KOMATE) registry: CORONARY ARTERY DISEASE

Journal of Interventional Cardiology

Volumn 22, Issue 5, 2009, Pages 411-419

  Kim, Byeong Keuk ^a   Oh, Seungjin ^a   Jeon, Dong Woon ^a   Yang, Joo Young ^a   Kim, Jung Sun ^b   Park, Sungha ^b   Choi, Donghoon ^b   Jang, Yangsoo ^b   Hong, Bum Kee ^b   Kwon, Hyuk Moon ^b   Lee, Seung Whan ^c   Goh, Choong Won ^d   Kwon, Kihwan ^e   Ryu, Sung Kee ^f  

^a National Health Insurance Corporation   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University Wonju College of Medicine   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e Mokdong Hospital   (South Korea)

^f Eulji University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RAPAMYCIN; TICLOPIDINE;

ADULT; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; DEATH; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; STENT THROMBOSIS; THERAPY EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KOREA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REGISTRIES; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; SURVIVAL RATE; THROMBOSIS; TREATMENT OUTCOME;

EID: 70349741104     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00495.x     Document Type: Article

References (23)

1. Moses JW, Leon MB, Popma JJ, et al. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 349 : 1315 1323.
2. Schofer J, Schluter M, Gershlick AH, et al. E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double blind, randomized controlled trial (E-SIRIUS). Lancet 2003 362 : 1093 1099.
3. Hassani SE, Chu WW, Wolfram RM, et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 2006 18 : 273 277.
4. Das P, Moliterno DJ, Charnigo R, et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 2006 18 : 405 408.
5. Halkin A, Selzer F, Marroquin O, et al. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol 2006 18 : 577 583.
6. Ishio N, Kobayashi Y, Takebayashi H, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007 71 : 1525 1529.
7. Aoyama T, Ishii H, Toriyama T, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008 72 : 56 60.
8. Kim BK, Oh S, Jeon DW, et al. Clinical outcomes following sirolimus-eluting stent implantation in patients with end-stage renal disease - Korean Multicenter Angioplasty Team (KOMATE) Registry. Korean Circ J 2006 36 : 424 430.
9. Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007 356 : 989 997.
10. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007 356 : 998 1008.
11. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007 356 : 1020 1029.
12. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993 329 : 673 682.
13. Marzocchi A, Saia F, Piovaccari G, et al. Long-term safety and efficacy of drug-eluting stents: Two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation 2007 115 : 3181 3188.
14. Jensen LO, Maeng M, Kaltoft A, et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007 50 : 463 470.
15. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007 370 : 937 948.
16. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005 293 : 2126 2130.
17. Mishkel GJ, Varghese JJ, Moore AL, et al. Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease. J Invasive Cardiol 2007 19 : 331 337.
18. Planer D, Beyar R, Almagor Y, et al. Long-term (>3 years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry). Am J Cardiol 2008 101 : 953 959.
19. Kastrati A, Mehilli J, Schuhlen H, et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004 350 : 232 238.
20. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents. N Engl J Med 2007 356 : 998 1008.
21. US Renal Data System. USRDS 2007 Annual Data Report, Bethesda : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
22. Robert N, Foley RN, Collins AJ. End-stage renal disease in the United States: An update from the United States Renal Data System. J Am Soc Nephrol 2007 18 : 2644 2648.
23. Azar RR, Prpic R, Ho KK, et al. Impactof end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000 86 : 485 489.